USFDA completes inspection at JB Chemicals’ Gujarat facility

03 Jul 2019 Evaluate

The US Food and Drug Administration (USFDA) has concluded inspection of JB Chemicals & Pharmaceuticals’ newly set up and commissioned solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat.

At the end of inspection, no objectionable observations were found and hence no Form 483 was issued. The said inspection was carried out from June 24, 2019 to June 28, 2019. This facility has capacity of 2 billion tablets per annum, which is expandable to 9 billion tablets per annum.

This new facility has already been approved by EU authorities in February 2019 and classified as cGMP compliant. The new facility will augment the company's manufacturing capacity for regulated markets like USA and EU as and when the product approvals are received.

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

1823.95 0.85 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×